CELL CALCIUM-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2115149, encodeId=413e21151496a, content=审稿速度:1.0 经验分享：一般审稿周期1-1.5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b85396303, createdName=ms8000001719481406, createdTime=Fri Feb 17 21:32:01 CST 2023, time=2023-02-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1088479, encodeId=77d110884e931, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088480, encodeId=e39c10884805e, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522027, encodeId=a6d852202ea7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个方向做的人越来越少了，杂志的影响力也是直线下降，希望能保住3.祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed May 04 23:38:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481583, encodeId=b9a4481583b3, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480660, encodeId=1f47480660db, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474159, encodeId=e8a94e41590d, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474160, encodeId=326e4e416043, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470368, encodeId=ebfb4e0368c6, content=我的文章已经被该杂志接受了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chjipe-同上, createdTime=Fri Mar 12 13:24:00 CST 2010, time=2010-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469972, encodeId=36e34699e299, content=经验分享！造福国人！国人投的不多，但难度还可以，我的文章审稿审了一个半月，每年发表110-120篇左右，本人11月投稿，稿号150左右，证明接受率还可以，建议相关细胞的钙基础研究可以考虑考虑。不过杂志相对专业，所以审稿人提的问题也会专业，需要一定的新意、理论基础和应对策略。本人先后投2点几，3点几都被拒，但之后投它（4点几）反而给了大修机会，面对2个审稿30个问题，也挺棘手，希望可以顺利接收吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 28 22:27:00 CST 2009, time=2009-12-28, status=1, ipAttribution=)]

2023-02-17 ms8000001719481406 来自河北省

审稿速度:1.0
经验分享：一般审稿周期1-1.5个月

75 0

[GetPortalCommentsPageByObjectIdResponse(id=2115149, encodeId=413e21151496a, content=审稿速度:1.0 经验分享：一般审稿周期1-1.5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b85396303, createdName=ms8000001719481406, createdTime=Fri Feb 17 21:32:01 CST 2023, time=2023-02-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1088479, encodeId=77d110884e931, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088480, encodeId=e39c10884805e, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522027, encodeId=a6d852202ea7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个方向做的人越来越少了，杂志的影响力也是直线下降，希望能保住3.祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed May 04 23:38:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481583, encodeId=b9a4481583b3, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480660, encodeId=1f47480660db, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474159, encodeId=e8a94e41590d, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474160, encodeId=326e4e416043, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470368, encodeId=ebfb4e0368c6, content=我的文章已经被该杂志接受了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chjipe-同上, createdTime=Fri Mar 12 13:24:00 CST 2010, time=2010-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469972, encodeId=36e34699e299, content=经验分享！造福国人！国人投的不多，但难度还可以，我的文章审稿审了一个半月，每年发表110-120篇左右，本人11月投稿，稿号150左右，证明接受率还可以，建议相关细胞的钙基础研究可以考虑考虑。不过杂志相对专业，所以审稿人提的问题也会专业，需要一定的新意、理论基础和应对策略。本人先后投2点几，3点几都被拒，但之后投它（4点几）反而给了大修机会，面对2个审稿30个问题，也挺棘手，希望可以顺利接收吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 28 22:27:00 CST 2009, time=2009-12-28, status=1, ipAttribution=)]

2021-12-28 ms6000000264964247

摘要一般控制在多少字符以内？

80 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2115149, encodeId=413e21151496a, content=审稿速度:1.0 经验分享：一般审稿周期1-1.5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b85396303, createdName=ms8000001719481406, createdTime=Fri Feb 17 21:32:01 CST 2023, time=2023-02-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1088479, encodeId=77d110884e931, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088480, encodeId=e39c10884805e, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522027, encodeId=a6d852202ea7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个方向做的人越来越少了，杂志的影响力也是直线下降，希望能保住3.祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed May 04 23:38:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481583, encodeId=b9a4481583b3, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480660, encodeId=1f47480660db, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474159, encodeId=e8a94e41590d, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474160, encodeId=326e4e416043, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470368, encodeId=ebfb4e0368c6, content=我的文章已经被该杂志接受了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chjipe-同上, createdTime=Fri Mar 12 13:24:00 CST 2010, time=2010-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469972, encodeId=36e34699e299, content=经验分享！造福国人！国人投的不多，但难度还可以，我的文章审稿审了一个半月，每年发表110-120篇左右，本人11月投稿，稿号150左右，证明接受率还可以，建议相关细胞的钙基础研究可以考虑考虑。不过杂志相对专业，所以审稿人提的问题也会专业，需要一定的新意、理论基础和应对策略。本人先后投2点几，3点几都被拒，但之后投它（4点几）反而给了大修机会，面对2个审稿30个问题，也挺棘手，希望可以顺利接收吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 28 22:27:00 CST 2009, time=2009-12-28, status=1, ipAttribution=)]

2021-12-27 rayms

什么时候需要highlights部分？

84 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2115149, encodeId=413e21151496a, content=审稿速度:1.0 经验分享：一般审稿周期1-1.5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b85396303, createdName=ms8000001719481406, createdTime=Fri Feb 17 21:32:01 CST 2023, time=2023-02-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1088479, encodeId=77d110884e931, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088480, encodeId=e39c10884805e, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522027, encodeId=a6d852202ea7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个方向做的人越来越少了，杂志的影响力也是直线下降，希望能保住3.祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed May 04 23:38:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481583, encodeId=b9a4481583b3, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480660, encodeId=1f47480660db, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474159, encodeId=e8a94e41590d, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474160, encodeId=326e4e416043, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470368, encodeId=ebfb4e0368c6, content=我的文章已经被该杂志接受了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chjipe-同上, createdTime=Fri Mar 12 13:24:00 CST 2010, time=2010-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469972, encodeId=36e34699e299, content=经验分享！造福国人！国人投的不多，但难度还可以，我的文章审稿审了一个半月，每年发表110-120篇左右，本人11月投稿，稿号150左右，证明接受率还可以，建议相关细胞的钙基础研究可以考虑考虑。不过杂志相对专业，所以审稿人提的问题也会专业，需要一定的新意、理论基础和应对策略。本人先后投2点几，3点几都被拒，但之后投它（4点几）反而给了大修机会，面对2个审稿30个问题，也挺棘手，希望可以顺利接收吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 28 22:27:00 CST 2009, time=2009-12-28, status=1, ipAttribution=)]

2016-05-04 fuhongxue007

审稿速度:3.0 | 投稿命中率:50.0
经验分享：这个方向做的人越来越少了，杂志的影响力也是直线下降，希望能保住3.祈祷！

290 0

[GetPortalCommentsPageByObjectIdResponse(id=2115149, encodeId=413e21151496a, content=审稿速度:1.0 经验分享：一般审稿周期1-1.5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b85396303, createdName=ms8000001719481406, createdTime=Fri Feb 17 21:32:01 CST 2023, time=2023-02-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1088479, encodeId=77d110884e931, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088480, encodeId=e39c10884805e, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522027, encodeId=a6d852202ea7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个方向做的人越来越少了，杂志的影响力也是直线下降，希望能保住3.祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed May 04 23:38:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481583, encodeId=b9a4481583b3, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480660, encodeId=1f47480660db, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474159, encodeId=e8a94e41590d, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474160, encodeId=326e4e416043, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470368, encodeId=ebfb4e0368c6, content=我的文章已经被该杂志接受了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chjipe-同上, createdTime=Fri Mar 12 13:24:00 CST 2010, time=2010-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469972, encodeId=36e34699e299, content=经验分享！造福国人！国人投的不多，但难度还可以，我的文章审稿审了一个半月，每年发表110-120篇左右，本人11月投稿，稿号150左右，证明接受率还可以，建议相关细胞的钙基础研究可以考虑考虑。不过杂志相对专业，所以审稿人提的问题也会专业，需要一定的新意、理论基础和应对策略。本人先后投2点几，3点几都被拒，但之后投它（4点几）反而给了大修机会，面对2个审稿30个问题，也挺棘手，希望可以顺利接收吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 28 22:27:00 CST 2009, time=2009-12-28, status=1, ipAttribution=)]

2011-06-29 med—doctor

明年会不会再跌呀，万一跌破怎么办？

423 0

[GetPortalCommentsPageByObjectIdResponse(id=2115149, encodeId=413e21151496a, content=审稿速度:1.0 经验分享：一般审稿周期1-1.5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b85396303, createdName=ms8000001719481406, createdTime=Fri Feb 17 21:32:01 CST 2023, time=2023-02-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1088479, encodeId=77d110884e931, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088480, encodeId=e39c10884805e, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522027, encodeId=a6d852202ea7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个方向做的人越来越少了，杂志的影响力也是直线下降，希望能保住3.祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed May 04 23:38:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481583, encodeId=b9a4481583b3, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480660, encodeId=1f47480660db, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474159, encodeId=e8a94e41590d, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474160, encodeId=326e4e416043, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470368, encodeId=ebfb4e0368c6, content=我的文章已经被该杂志接受了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chjipe-同上, createdTime=Fri Mar 12 13:24:00 CST 2010, time=2010-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469972, encodeId=36e34699e299, content=经验分享！造福国人！国人投的不多，但难度还可以，我的文章审稿审了一个半月，每年发表110-120篇左右，本人11月投稿，稿号150左右，证明接受率还可以，建议相关细胞的钙基础研究可以考虑考虑。不过杂志相对专业，所以审稿人提的问题也会专业，需要一定的新意、理论基础和应对策略。本人先后投2点几，3点几都被拒，但之后投它（4点几）反而给了大修机会，面对2个审稿30个问题，也挺棘手，希望可以顺利接收吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 28 22:27:00 CST 2009, time=2009-12-28, status=1, ipAttribution=)]

2011-06-29 bio_mini

明年会不会降到3分呀，如果降3分以下就不值了

398 0

[GetPortalCommentsPageByObjectIdResponse(id=2115149, encodeId=413e21151496a, content=审稿速度:1.0 经验分享：一般审稿周期1-1.5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b85396303, createdName=ms8000001719481406, createdTime=Fri Feb 17 21:32:01 CST 2023, time=2023-02-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1088479, encodeId=77d110884e931, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088480, encodeId=e39c10884805e, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522027, encodeId=a6d852202ea7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个方向做的人越来越少了，杂志的影响力也是直线下降，希望能保住3.祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed May 04 23:38:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481583, encodeId=b9a4481583b3, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480660, encodeId=1f47480660db, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474159, encodeId=e8a94e41590d, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474160, encodeId=326e4e416043, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470368, encodeId=ebfb4e0368c6, content=我的文章已经被该杂志接受了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chjipe-同上, createdTime=Fri Mar 12 13:24:00 CST 2010, time=2010-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469972, encodeId=36e34699e299, content=经验分享！造福国人！国人投的不多，但难度还可以，我的文章审稿审了一个半月，每年发表110-120篇左右，本人11月投稿，稿号150左右，证明接受率还可以，建议相关细胞的钙基础研究可以考虑考虑。不过杂志相对专业，所以审稿人提的问题也会专业，需要一定的新意、理论基础和应对策略。本人先后投2点几，3点几都被拒，但之后投它（4点几）反而给了大修机会，面对2个审稿30个问题，也挺棘手，希望可以顺利接收吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 28 22:27:00 CST 2009, time=2009-12-28, status=1, ipAttribution=)]

2011-03-09 匿名用户

审稿速度:3.0 | 投稿命中率:80.0
经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。

388 0

[GetPortalCommentsPageByObjectIdResponse(id=2115149, encodeId=413e21151496a, content=审稿速度:1.0 经验分享：一般审稿周期1-1.5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b85396303, createdName=ms8000001719481406, createdTime=Fri Feb 17 21:32:01 CST 2023, time=2023-02-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1088479, encodeId=77d110884e931, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088480, encodeId=e39c10884805e, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522027, encodeId=a6d852202ea7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个方向做的人越来越少了，杂志的影响力也是直线下降，希望能保住3.祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed May 04 23:38:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481583, encodeId=b9a4481583b3, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480660, encodeId=1f47480660db, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474159, encodeId=e8a94e41590d, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474160, encodeId=326e4e416043, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470368, encodeId=ebfb4e0368c6, content=我的文章已经被该杂志接受了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chjipe-同上, createdTime=Fri Mar 12 13:24:00 CST 2010, time=2010-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469972, encodeId=36e34699e299, content=经验分享！造福国人！国人投的不多，但难度还可以，我的文章审稿审了一个半月，每年发表110-120篇左右，本人11月投稿，稿号150左右，证明接受率还可以，建议相关细胞的钙基础研究可以考虑考虑。不过杂志相对专业，所以审稿人提的问题也会专业，需要一定的新意、理论基础和应对策略。本人先后投2点几，3点几都被拒，但之后投它（4点几）反而给了大修机会，面对2个审稿30个问题，也挺棘手，希望可以顺利接收吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 28 22:27:00 CST 2009, time=2009-12-28, status=1, ipAttribution=)]

2011-03-09 匿名用户

审稿速度:3.0 | 投稿命中率:80.0
经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。

418 0

[GetPortalCommentsPageByObjectIdResponse(id=2115149, encodeId=413e21151496a, content=审稿速度:1.0 经验分享：一般审稿周期1-1.5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b85396303, createdName=ms8000001719481406, createdTime=Fri Feb 17 21:32:01 CST 2023, time=2023-02-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1088479, encodeId=77d110884e931, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088480, encodeId=e39c10884805e, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522027, encodeId=a6d852202ea7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个方向做的人越来越少了，杂志的影响力也是直线下降，希望能保住3.祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed May 04 23:38:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481583, encodeId=b9a4481583b3, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480660, encodeId=1f47480660db, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474159, encodeId=e8a94e41590d, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474160, encodeId=326e4e416043, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470368, encodeId=ebfb4e0368c6, content=我的文章已经被该杂志接受了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chjipe-同上, createdTime=Fri Mar 12 13:24:00 CST 2010, time=2010-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469972, encodeId=36e34699e299, content=经验分享！造福国人！国人投的不多，但难度还可以，我的文章审稿审了一个半月，每年发表110-120篇左右，本人11月投稿，稿号150左右，证明接受率还可以，建议相关细胞的钙基础研究可以考虑考虑。不过杂志相对专业，所以审稿人提的问题也会专业，需要一定的新意、理论基础和应对策略。本人先后投2点几，3点几都被拒，但之后投它（4点几）反而给了大修机会，面对2个审稿30个问题，也挺棘手，希望可以顺利接收吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 28 22:27:00 CST 2009, time=2009-12-28, status=1, ipAttribution=)]

2010-03-12 chjipe-同上

我的文章已经被该杂志接受了！

435 0

[GetPortalCommentsPageByObjectIdResponse(id=2115149, encodeId=413e21151496a, content=审稿速度:1.0 经验分享：一般审稿周期1-1.5个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b85396303, createdName=ms8000001719481406, createdTime=Fri Feb 17 21:32:01 CST 2023, time=2023-02-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1088479, encodeId=77d110884e931, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088480, encodeId=e39c10884805e, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522027, encodeId=a6d852202ea7, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个方向做的人越来越少了，杂志的影响力也是直线下降，希望能保住3.祈祷！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c61619217, createdName=fuhongxue007, createdTime=Wed May 04 23:38:00 CST 2016, time=2016-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481583, encodeId=b9a4481583b3, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480660, encodeId=1f47480660db, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474159, encodeId=e8a94e41590d, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474160, encodeId=326e4e416043, content=审稿速度:3.0 | 投稿命中率:80.0 经验分享：与同类杂志相比，还是比较好投的。而且现在进行钙研究，没有十年前这么热，因此，是比较好的机会，做得系统一些。易中的主要是分子生物学结合钙成像或电生理研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 09 12:35:00 CST 2011, time=2011-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=470368, encodeId=ebfb4e0368c6, content=我的文章已经被该杂志接受了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chjipe-同上, createdTime=Fri Mar 12 13:24:00 CST 2010, time=2010-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469972, encodeId=36e34699e299, content=经验分享！造福国人！国人投的不多，但难度还可以，我的文章审稿审了一个半月，每年发表110-120篇左右，本人11月投稿，稿号150左右，证明接受率还可以，建议相关细胞的钙基础研究可以考虑考虑。不过杂志相对专业，所以审稿人提的问题也会专业，需要一定的新意、理论基础和应对策略。本人先后投2点几，3点几都被拒，但之后投它（4点几）反而给了大修机会，面对2个审稿30个问题，也挺棘手，希望可以顺利接收吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=437, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Dec 28 22:27:00 CST 2009, time=2009-12-28, status=1, ipAttribution=)]

2009-12-28 匿名用户

经验分享！造福国人！国人投的不多，但难度还可以，我的文章审稿审了一个半月，每年发表110-120篇左右，本人11月投稿，稿号150左右，证明接受率还可以，建议相关细胞的钙基础研究可以考虑考虑。不过杂志相对专业，所以审稿人提的问题也会专业，需要一定的新意、理论基础和应对策略。本人先后投2点几，3点几都被拒，但之后投它（4点几）反而给了大修机会，面对2个审稿30个问题，也挺棘手，希望可以顺利接收吧！

437 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务